Keybank National Association OH Purchases 2,056 Shares of Waters Corporation $WAT

Keybank National Association OH boosted its position in Waters Corporation (NYSE:WAT) by 113.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,876 shares of the medical instruments supplier’s stock after purchasing an additional 2,056 shares during the quarter. Keybank National Association OH’s holdings in Waters were worth $1,154,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in WAT. Zions Bancorporation National Association UT grew its position in shares of Waters by 121.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 40 shares during the period. SHP Wealth Management bought a new stake in Waters during the fourth quarter worth about $32,000. DV Equities LLC purchased a new stake in Waters in the fourth quarter worth about $32,000. Louisbourg Investments Inc. bought a new position in shares of Waters during the first quarter valued at approximately $30,000. Finally, North Star Investment Management Corp. lifted its holdings in shares of Waters by 10,200.0% during the first quarter. North Star Investment Management Corp. now owns 103 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 102 shares during the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $350.00 price objective on shares of Waters in a research note on Thursday, May 7th. Robert W. Baird set a $387.00 price objective on shares of Waters in a research note on Wednesday, May 6th. Sanford C. Bernstein started coverage on shares of Waters in a report on Friday, June 26th. They set an “outperform” rating and a $435.00 price target on the stock. Wolfe Research started coverage on Waters in a research report on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 price objective on the stock. Finally, TD Cowen increased their target price on Waters from $345.00 to $385.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Four analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Waters currently has a consensus rating of “Moderate Buy” and a consensus price target of $399.84.

Waters Stock Down 1.0%

Shares of Waters stock opened at $374.94 on Wednesday. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. The company’s 50 day moving average is $354.18 and its 200 day moving average is $346.74. The company has a market cap of $36.82 billion, a price-to-earnings ratio of 47.64, a price-to-earnings-growth ratio of 2.29 and a beta of 1.20.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. Waters had a net margin of 11.91% and a return on equity of 15.60%. The firm’s revenue was up 91.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.25 EPS. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Research analysts anticipate that Waters Corporation will post 14.51 EPS for the current year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.